Cawachi Limited (2664.T)
JPY 2510.0
(-0.08%)
JPY 2510.0
(-0.08%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 11.85 Billion JPY | -2.23% |
| 2022 | 10.9 Billion JPY | -8.4% |
| 2021 | 12.06 Billion JPY | -18.24% |
| 2020 | 14.96 Billion JPY | 43.07% |
| 2019 | 10.18 Billion JPY | 3.92% |
| 2018 | 8.88 Billion JPY | -5.06% |
| 2017 | 9.55 Billion JPY | -8.06% |
| 2016 | 10.64 Billion JPY | 7.8% |
| 2015 | 9.74 Billion JPY | 23.18% |
| 2014 | 1.97 Billion JPY | -28.07% |
| 2013 | 11.63 Billion JPY | -6.34% |
| 2012 | 10.83 Billion JPY | -11.54% |
| 2011 | 14.1 Billion JPY | 14.0% |
| 2010 | 12.32 Billion JPY | 0.66% |
| 2009 | 13.01 Billion JPY | -2.66% |
| 2008 | 13.53 Billion JPY | -11.54% |
| 2007 | 15.68 Billion JPY | -8.28% |
| 2006 | 14.7 Billion JPY | -9.18% |
| 2005 | 12.21 Billion JPY | -6.26% |
| 2004 | 17.68 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.64 Billion JPY | 54.08% |
| 2024 Q2 | 2.35 Billion JPY | 21.6% |
| 2023 Q2 | 2.9 Billion JPY | 40.94% |
| 2023 FY | - JPY | -2.23% |
| 2023 Q4 | 2.68 Billion JPY | 34.99% |
| 2023 Q3 | 1.98 Billion JPY | -31.56% |
| 2023 Q1 | 2.05 Billion JPY | 81.89% |
| 2022 Q2 | 2.75 Billion JPY | 48.25% |
| 2022 Q1 | 1.85 Billion JPY | 8.21% |
| 2022 FY | - JPY | -8.4% |
| 2022 Q4 | 1.13 Billion JPY | -44.1% |
| 2022 Q3 | 2.02 Billion JPY | -26.52% |
| 2021 Q1 | 2.15 Billion JPY | -0.37% |
| 2021 FY | - JPY | -18.24% |
| 2021 Q4 | 1.71 Billion JPY | -17.4% |
| 2021 Q2 | 2.85 Billion JPY | 32.79% |
| 2021 Q3 | 2.08 Billion JPY | -27.25% |
| 2020 Q3 | 2.46 Billion JPY | -32.51% |
| 2020 FY | - JPY | 43.07% |
| 2020 Q1 | 3.42 Billion JPY | 65.96% |
| 2020 Q2 | 3.65 Billion JPY | 6.71% |
| 2020 Q4 | 2.16 Billion JPY | -12.44% |
| 2019 Q2 | 2.05 Billion JPY | 87.5% |
| 2019 Q4 | 2.06 Billion JPY | 36.75% |
| 2019 FY | - JPY | 3.92% |
| 2019 Q1 | 1.09 Billion JPY | 35.64% |
| 2019 Q3 | 1.51 Billion JPY | -26.52% |
| 2018 Q2 | 2.07 Billion JPY | 47.34% |
| 2018 Q4 | 808 Million JPY | -44.01% |
| 2018 FY | - JPY | -5.06% |
| 2018 Q1 | 1.41 Billion JPY | 24.1% |
| 2018 Q3 | 1.44 Billion JPY | -30.59% |
| 2017 Q3 | 1.17 Billion JPY | -45.56% |
| 2017 FY | - JPY | -8.06% |
| 2017 Q2 | 2.15 Billion JPY | 15.81% |
| 2017 Q1 | 1.85 Billion JPY | 13.28% |
| 2017 Q4 | 1.13 Billion JPY | -2.99% |
| 2016 Q4 | 1.64 Billion JPY | -4.81% |
| 2016 Q3 | 1.72 Billion JPY | -20.19% |
| 2016 FY | - JPY | 7.8% |
| 2016 Q2 | 2.16 Billion JPY | 17.14% |
| 2016 Q1 | 1.84 Billion JPY | 2.56% |
| 2015 Q3 | 1.33 Billion JPY | -22.67% |
| 2015 Q1 | 1.41 Billion JPY | 194.79% |
| 2015 Q4 | 1.79 Billion JPY | 35.19% |
| 2015 FY | - JPY | 23.18% |
| 2015 Q2 | 1.72 Billion JPY | 21.55% |
| 2014 FY | - JPY | -28.07% |
| 2014 Q2 | 1.17 Billion JPY | -19.86% |
| 2014 Q4 | 480 Million JPY | -55.72% |
| 2014 Q3 | 1.08 Billion JPY | -7.35% |
| 2014 Q1 | 1.46 Billion JPY | -36.6% |
| 2013 Q4 | 2.3 Billion JPY | 29.6% |
| 2013 Q2 | 2.32 Billion JPY | 11.78% |
| 2013 FY | - JPY | -6.34% |
| 2013 Q1 | 2.08 Billion JPY | -13.91% |
| 2013 Q3 | 1.77 Billion JPY | -23.57% |
| 2012 FY | - JPY | -11.54% |
| 2012 Q3 | 1.87 Billion JPY | -35.3% |
| 2012 Q2 | 2.9 Billion JPY | 40.9% |
| 2012 Q4 | 2.41 Billion JPY | 28.58% |
| 2012 Q1 | 2.06 Billion JPY | -49.93% |
| 2011 Q2 | 4.54 Billion JPY | 21.07% |
| 2011 Q1 | 3.75 Billion JPY | 7.63% |
| 2011 FY | - JPY | 14.0% |
| 2011 Q4 | 4.11 Billion JPY | 22.87% |
| 2011 Q3 | 3.35 Billion JPY | -26.21% |
| 2010 FY | - JPY | 0.66% |
| 2010 Q2 | 4.19 Billion JPY | 50.14% |
| 2010 Q4 | 3.48 Billion JPY | 4.19% |
| 2010 Q3 | 3.34 Billion JPY | -20.34% |
| 2010 Q1 | 2.79 Billion JPY | -7.81% |
| 2009 Q1 | 3.17 Billion JPY | 0.0% |
| 2009 Q2 | 4.03 Billion JPY | 26.77% |
| 2009 Q3 | 3.48 Billion JPY | -13.42% |
| 2009 Q4 | 3.03 Billion JPY | -13.07% |
| 2009 FY | - JPY | -2.66% |
| 2008 FY | - JPY | -11.54% |
| 2007 FY | - JPY | -8.28% |
| 2006 FY | - JPY | -9.18% |
| 2005 FY | - JPY | -6.26% |
| 2004 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HEARTSEED INC | -1.44 Billion JPY | 918.358% |
| Pharmarise Holdings Corporation | 2.08 Billion JPY | -468.169% |
| Qol Holdings Co., Ltd. | 14.21 Billion JPY | 16.6% |
| MatsukiyoCocokara & Co. | 98.01 Billion JPY | 87.908% |
| Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 82.474% |
| Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 51.322% |
| NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | 19.127% |
| COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 76.953% |
| Tsuruha Holdings Inc. | 67.2 Billion JPY | 82.365% |
| Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | -210.587% |
| Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -337.021% |
| Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 61.32% |
| Medical System Network Co., Ltd. | 6.99 Billion JPY | -69.411% |
| Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | -182.999% |
| Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 76.644% |
| YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | -45.192% |
| Astena Holdings Co., Ltd. | 4.17 Billion JPY | -184.069% |
| Genky DrugStores Co., Ltd. | 14.47 Billion JPY | 18.115% |
| Ain Holdings Inc. | 31.22 Billion JPY | 62.04% |
| Sundrug Co.,Ltd. | 56.23 Billion JPY | 78.926% |